However, a negative correlation between IGF-1 and IGF-1R expressions and caecal/colonic-adherent and fecal viable bacteria was observed (p < 0.05) (Table S2); thus, the significant protection against adenocarcinoma development observed in BF-treated groups is confirmed. The gene discussed is IGF1; the disease is adenocarcinoma.